Add like
Add dislike
Add to saved papers

Baseline left atrial low voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results.

BACKGROUND AND AIMS: Electroanatomical mapping may be critical to identify atrial fibrillation (AF) subjects that require substrate modification beyond pulmonary vein isolation (PVI). The objective was to determine correlations between pre-ablation mapping characteristics and 12-month outcomes after a single PVI-only catheter ablation of AF.

METHODS: This study enrolled paroxysmal AF (PAF), early persistent AF (PsAF; 7 days-3 months) and non-early PsAF (>3 months-12 months) subjects undergoing de novo PVI-only radiofrequency catheter ablation. Sinus rhythm and AF voltage maps were created with the Advisor HD Grid™ Mapping Catheter, Sensor Enabled™ for each subject and presence of low voltage area (low voltage cutoffs: 0.1 mV-1.5 mV) was investigated. Follow-up visits were at 3-, 6- and 12-months, with a 24-hour Holter monitor at 12-months. A Cox proportional hazards model identified associations between mapping data and 12-month recurrence after a single PVI procedure.

RESULTS: The study enrolled 300 subjects (113 PAF, 86 early PsAF, 101 non-early PsAF) at 18 centers. At 12-months, 75.5% of subjects were free from AF/atrial flutter (AFL)/atrial tachycardia (AT) recurrence. Univariate analysis found arrhythmia recurrence did not correlate with AF diagnosis, but low voltage area was significantly correlated. Low voltage area (<0.5 mV) greater than 28% of the left atrium in sinus rhythm (HR:4.82, 95% CI:2.08-11.18, p = 0.0003) and greater than 72% in AF (HR:5.66, 95% CI:2.34-13.69, p = 0.0001) was associated with higher risk of AF/AFL/AT recurrence at 12-months.

CONCLUSION: Larger extension of low voltage area was associated with increased risk of arrhythmia recurrence. These subjects may benefit from substrate modification beyond PVI.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app